Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression

Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression

Triple-negative breast cancer (TNBC) is often treated with anthracyclines (e.g., epirubicin or doxorubicin), but very little is known about anthracycline resistance, especially epirubicin resistance in TNBC. To identify novel long noncoding RNAs (lncRNAs) involved in epirubicin resistance in TNBC, w...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Fengliang Wang, Sujin Yang, Mingming Lv, Fei Chen, Hong Yin, Sheng Gao, Jinhai Tang, Jing Yu
Formaat: Artikel
Taal:English
Gepubliceerd in: Frontiers Media S.A. 2021-03-01
Reeks:Frontiers in Oncology
Onderwerpen:
triple-negative breast cancer
epirubicin resistance
long noncoding RNA
ITGB1
MDA-MB-231
Online toegang:https://www.frontiersin.org/articles/10.3389/fonc.2021.592215/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.592215/full

Gelijkaardige items